ORCHID PHARMA
Back to Cashflow Statement
|
ORCHID PHARMA Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹19 Cr | ₹126 Cr | ₹18 Cr | ₹92 Cr | ₹24 Cr |
What is the latest Cash Flow from Operating Activities ratio of ORCHID PHARMA ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2025 | ₹19 Cr |
| Mar2024 | ₹126 Cr |
| Mar2023 | ₹18 Cr |
| Mar2022 | ₹92 Cr |
| Mar2021 | ₹24 Cr |
How is Cash Flow from Operating Activities of ORCHID PHARMA Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹19 Cr | -84.75 | |
| Mar2024 | ₹126 Cr | 587.05 | |
| Mar2023 | ₹18 Cr | -80.17 | |
| Mar2022 | ₹92 Cr | 292.08 | |
| Mar2021 | ₹24 Cr | - | |
Compare Cash Flow from Operating Activities of peers of ORCHID PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ORCHID PHARMA | ₹3,142.6 Cr | -6.8% | -11.3% | -31.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹417,028.0 Cr | 0.3% | 9% | 8.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹170,237.0 Cr | 1.9% | 5.9% | 12.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹146,801.0 Cr | 0.6% | 9.5% | 45% | Stock Analytics | |
| CIPLA | ₹108,861.0 Cr | 1.6% | 1.8% | -7.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,435.0 Cr | -1.5% | 5.7% | 14.5% | Stock Analytics | |
ORCHID PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ORCHID PHARMA | -6.8% |
-11.3% |
-31.6% |
| SENSEX | -1.8% |
-1.6% |
7.3% |
You may also like the below Video Courses